Literature DB >> 19026152

Mortality in idiopathic inflammatory myopathies.

I E Lundberg1, C J Forbess.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19026152

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  14 in total

1.  Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; Frederick W Miller
Journal:  JAMA       Date:  2011-01-12       Impact factor: 56.272

2.  Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults.

Authors:  Latika Gupta; Smriti Chaurasia; Puja Srivastava; Sanjay Dwivedi; Able Lawrence; Ramnath Misra
Journal:  Clin Rheumatol       Date:  2018-03-07       Impact factor: 2.980

3.  Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.

Authors:  Adam M Huber; Gulnara Mamyrova; Peter A Lachenbruch; Julia A Lee; James D Katz; Ira N Targoff; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-05       Impact factor: 4.794

4.  Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey.

Authors:  Christina Charles-Schoeman; Sogol S Amjadi; Harold E Paulus
Journal:  Clin Rheumatol       Date:  2012-04-21       Impact factor: 2.980

5.  Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain.

Authors:  Laura Nuño-Nuño; Beatriz Esther Joven; Patricia E Carreira; Valentina Maldonado-Romero; Carmen Larena-Grijalba; Irene Llorente Cubas; Eva Gloria Tomero; María Carmen Barbadillo-Mateos; Paloma García De la Peña Lefebvre; Lucía Ruiz-Gutiérrez; Juan Carlos López-Robledillo; Henry Moruno-Cruz; Ana Pérez; Tatiana Cobo-Ibáñez; Raquel Almodóvar González; Leticia Lojo; María Jesús García De Yébenes; Francisco Javier López-Longo
Journal:  Rheumatol Int       Date:  2017-09-02       Impact factor: 2.631

6.  Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index.

Authors:  Lisa G Rider; Peter A Lachenbruch; Jason B Monroe; Angelo Ravelli; Imelda Cabalar; Brian M Feldman; Maria L Villalba; Barry L Myones; Lauren M Pachman; Robert M Rennebohm; Ann M Reed; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2009-11

7.  Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis.

Authors:  Augusto H Santo; José Maria P Souza; Celso E Pinheiro; Deborah Cc Souza; Emilia I Sato
Journal:  BMC Public Health       Date:  2010-10-11       Impact factor: 3.295

8.  Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China.

Authors:  Xiao Ming Shu; Xin Lu; Yao Xie; Guo Chun Wang
Journal:  BMC Neurol       Date:  2011-11-09       Impact factor: 2.474

9.  Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.

Authors:  Elena Schiopu; Kristine Phillips; Paul M MacDonald; Leslie J Crofford; Emily C Somers
Journal:  Arthritis Res Ther       Date:  2012-01-27       Impact factor: 5.156

10.  Genetic association study of NF-κB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy.

Authors:  Hector Chinoy; Charles K-C Li; Hazel Platt; Noreen Fertig; Hemlata Varsani; Harsha Gunawardena; Zoe Betteridge; Chester V Oddis; Neil J McHugh; Lucy R Wedderburn; William E R Ollier; Robert G Cooper
Journal:  Rheumatology (Oxford)       Date:  2011-12-30       Impact factor: 7.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.